Selective serotonin reuptake inhibitors and bleeding risk after PCI. A propensity score matching study

MLA

Rafael González-Manzanares, et al. “Selective Serotonin Reuptake Inhibitors and Bleeding Risk after PCI. A Propensity Score Matching Study.” REC: Interventional Cardiology (English Ed.), vol. 4, no. 2, May 2022, pp. 115–22. EBSCOhost, https://doi.org/10.24875/RECICE.M22000268.

APA

Rafael González-Manzanares, Soledad Ojeda, Francisco Hidalgo, Marina Ruiz-Moreno, Consuelo Fernández-Avilés, Francesco Costa, Guisela Flores-Vergara, Javier Suárez de Lezo, Luz Carmona-Artime, & Manuel Pan. (2022). Selective serotonin reuptake inhibitors and bleeding risk after PCI. A propensity score matching study. REC: Interventional Cardiology (English Ed.), 4(2), 115–122. https://doi.org/10.24875/RECICE.M22000268

Chicago

Rafael González-Manzanares, Soledad Ojeda, Francisco Hidalgo, Marina Ruiz-Moreno, Consuelo Fernández-Avilés, Francesco Costa, Guisela Flores-Vergara, Javier Suárez de Lezo, Luz Carmona-Artime, and Manuel Pan. 2022. “Selective Serotonin Reuptake Inhibitors and Bleeding Risk after PCI. A Propensity Score Matching Study.” REC: Interventional Cardiology (English Ed.) 4 (2): 115–22. doi:10.24875/RECICE.M22000268.